Ecuador site

Ecuador

Production Site Ecuador

Our Quito site is the largest manufacturing plant for solid and semi-solid pharmaceuticals in Ecuador. It is Grünenthal’s central production facility, pharmaceutical development center and logistics hub in Latin America.

Our site in Quito is recognized as a preferred contract manufacturer throughout Latin America. Various multinational corporations are among our customers – and many of them have been with us for years. The experts in Ecuador can manufacture a variety of formulations such as granules, coated tablets, capsules, liquids, semi-solids and packaging in various blister, sachet or bottle forms.

Covering 50,000 m2, the plant north of Quito guarantees Grünenthal’s high quality standards. It is certified by various Latin American authorities such as ANVISA (Brazil), INVIMA (Colombia) as well as by European authorities (covering also Cofepris, Mexico). It is one of the few facilities in Latin America licensed to export to Europe and the only one in Ecuador with an EU Good Manufacturing Practice certificate.

Starting in 2025, a newly built 1,800-square-metre facility will enable the production of up to 300 million high-quality tablets annually to serve pain patients across 17 European countries.

Full service in Latin America

Tour (in Spanish) of our primary manufacturing site for supply of solid, semi-solid and liquid products throughout Latin America (amongst others approved by EMA, ANVISA, INVIMA).

Contact information:


Tecnandina S.A.

Av. Manuel Córdova Galarza Km 6 1/2 Vía a la Mitad del Mundo (Pusuquí)

Quito

Ecuador


Phone +593 2989 111

Contact form

Great Place To Work